EUROPE: +33 (0) 972 476 029 - USA: + 1 (617)-416-5358

The latest news on Genoskin

Check our latest news below. For more info - contact us!

Contact us

Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin

  8 November 2021

Read more

De-risking antiaging trials with ex vivo skin models

  28 October 2021

Read more

Genoskin launches the ISR platform®

  6 July 2021

Read more

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

  15 June 2021

Read more

Injection site reactions platform

  10 June 2021

Read more

Interview with Pr. Guy Serre

  9 June 2021

Read more

Using NativeSkin® to study poison ivy-induced dermatitis

  22 February 2021

Read more

Human connective tissue mast cells

  30 November 2020

Read more

Top things found in human skin!

  20 November 2020

Read more

A unique ex vivo perfused human skin model to test pharmacokinetic and systemic administration in human skin

  28 October 2020

Read more

Genoskin awarded the Healthtech prize “Transformons la France!”

  16 October 2020

Read more

Genoskin answers questions from National Anti-Vivisection Society

  7 October 2020

Read more

Genoskin & LEO Pharma publish data on inflammation model InflammaSkin® in Experimental Dermatology

  2 October 2020

Read more

Pharma’s Almanac: Overcoming skin assays challenges with living human skin models

  30 September 2020

Read more

Genoskin launches new offering: NativeSkin access

  4 September 2020

Read more

Genoskin in the News: article on Benzinga

  13 August 2020

Read more

Genoskin’s CEO invited to talk at Empowered Patient Podcast

  28 July 2020

Read more

Brand new sustainable and user-friendly packaging!

  6 July 2020

Read more

Genoskin to attend BIO Digital 2020 next week

  4 June 2020

Read more

Genoskin featured in a Business Insider article

  16 May 2020

Read more